Toggle Main Menu Toggle Search

Open Access padlockePrints

Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy

Lookup NU author(s): Dr Matthew Thomas, Professor Timothy Cheetham

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2018 Walter de Gruyter GmbH, Berlin/Boston. The dose of hydrocortisone therapy required to maintain normal growth in infants with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is lower than in later childhood. This reflects the presence of excess non-aromatisable rather than aromatisable androgen but there has been relatively little focus on the role of mineralocorticoid therapy. Growth data of infants with CAH due to 21-hydroxylase deficiency (2008-2016) were reviewed and information regarding hydrocortisone and fludrocortisone regimen was collected. Change in height standard deviation (SD) and height velocity standard deviation score (SDS) were analysed during the first year of life. Growth data from 13 children (8 M) were analysed. Height (length) declined from a median of -0.69 SD at 3 months to -1.23 SD at 12 months with a reduction in height velocity SDS from 0.02 between 3 and 6 months to -2.22 between 9 and 12 months (p=0.017) despite a hydrocortisone dose at the lower end of the range as recommended in consensus guidelines. The glucocorticoid activity of hydrocortisone and fludrocortisone was negatively associated with growth velocity (r=-0.55; p=0.049) although renin activity was not suppressed. Infants with 21-hydroxylase deficiency can be managed with replacement hydrocortisone. The reasons for this paradigm are now understood although our data confirm that the glucocorticoid activity of fludrocortisone needs to be taken into consideration as well.


Publication metadata

Author(s): Sellick J, Aldridge S, Thomas M, Cheetham T

Publication type: Article

Publication status: Published

Journal: Journal of Pediatric Endocrinology and Metabolism

Year: 2018

Volume: 31

Issue: 9

Pages: 1019-1022

Online publication date: 03/09/2018

Acceptance date: 02/08/2018

ISSN (print): 0334-018X

ISSN (electronic): 2191-0251

Publisher: De Gruyter

URL: https://doi.org/10.1515/jpem-2018-0260

DOI: 10.1515/jpem-2018-0260


Altmetrics

Altmetrics provided by Altmetric


Share